Moore Capital Management LP Has Cut Its Clovis Oncology (CLVS) Position; Cypress Capital Management Wy Boosted Alaska Air Group (ALK) Holding By $47.12 Million

December 9, 2017 - By Winifred Garcia

Moore Capital Management Lp decreased Clovis Oncology Inc (CLVS) stake by 75% reported in 2017Q2 SEC filing. Moore Capital Management Lp sold 30,000 shares as Clovis Oncology Inc (CLVS)’s stock declined 20.61%. The Moore Capital Management Lp holds 10,000 shares with $936,000 value, down from 40,000 last quarter. Clovis Oncology Inc now has $3.05B valuation. The stock increased 4.47% or $2.66 during the last trading session, reaching $62.15. About 1.51M shares traded or 9.15% up from the average. Clovis Oncology, Inc. (NASDAQ:CLVS) has risen 282.71% since December 9, 2016 and is uptrending. It has outperformed by 266.01% the S&P500.

Cypress Capital Management Llc Wy increased Alaska Air Group (ALK) stake by 18.26% reported in 2017Q2 SEC filing. Cypress Capital Management Llc Wy acquired 525 shares as Alaska Air Group (ALK)’s stock declined 12.45%. The Cypress Capital Management Llc Wy holds 3,400 shares with $305.18 million value, up from 2,875 last quarter. Alaska Air Group now has $8.58 billion valuation. The stock increased 0.53% or $0.37 during the last trading session, reaching $69.74. About 1.07M shares traded. Alaska Air Group, Inc. (NYSE:ALK) has risen 29.33% since December 9, 2016 and is uptrending. It has outperformed by 12.63% the S&P500.

Cypress Capital Management Llc Wy decreased Transmontaigne Partners LP (NYSE:TLP) stake by 3,900 shares to 850 valued at $35.70 million in 2017Q2. It also reduced Zions Bancorporation (NASDAQ:ZION) stake by 3,790 shares and now owns 235 shares. Adobe Sys Inc (NASDAQ:ADBE) was reduced too.

Investors sentiment increased to 1.15 in Q2 2017. Its up 0.04, from 1.11 in 2017Q1. It is positive, as 51 investors sold ALK shares while 150 reduced holdings. 64 funds opened positions while 168 raised stakes. 106.39 million shares or 3.26% less from 109.97 million shares in 2017Q1 were reported. Aperio Group Limited Liability Company invested 0.03% of its portfolio in Alaska Air Group, Inc. (NYSE:ALK). Soros Fund Mngmt Ltd Liability Corp accumulated 3,800 shares. Canada Pension Plan Invest Board accumulated 140,800 shares or 0.03% of the stock. Barnett & invested in 40,235 shares. Pathstone Family Office Ltd Liability Com owns 11 shares. The Connecticut-based Ellington Management Grp Limited Liability Co has invested 0.05% in Alaska Air Group, Inc. (NYSE:ALK). West Oak Cap Llc owns 100 shares. Lenox Wealth invested 0% of its portfolio in Alaska Air Group, Inc. (NYSE:ALK). Smead Mgmt Incorporated owns 1.88% invested in Alaska Air Group, Inc. (NYSE:ALK) for 434,640 shares. Intl, a New York-based fund reported 42,551 shares. Jag Cap Mgmt Limited Liability Corp reported 9,500 shares stake. Dreman Value Mngmt L L C has invested 0.28% of its portfolio in Alaska Air Group, Inc. (NYSE:ALK). Fund Sa holds 0.03% or 40,619 shares in its portfolio. Jefferies Group Inc Ltd Llc holds 0.03% of its portfolio in Alaska Air Group, Inc. (NYSE:ALK) for 51,224 shares. Victory Management Inc holds 468,429 shares.

Among 15 analysts covering Alaska Air Group (NYSE:ALK), 9 have Buy rating, 0 Sell and 6 Hold. Therefore 60% are positive. Alaska Air Group had 69 analyst reports since July 24, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Alaska Air Group, Inc. (NYSE:ALK) rating on Thursday, September 21. Stifel Nicolaus has “Buy” rating and $125.0 target. The rating was downgraded by Stifel Nicolaus to “Hold” on Tuesday, December 22. JP Morgan maintained the shares of ALK in report on Thursday, February 4 with “Underweight” rating. The rating was upgraded by Cowen & Co on Monday, April 24 to “Outperform”. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, October 26. The firm has “In-Line” rating by Imperial Capital given on Friday, October 21. The firm earned “Buy” rating on Thursday, October 13 by Buckingham Research. Cowen & Co reinitiated the shares of ALK in report on Monday, May 16 with “Outperform” rating. The firm has “Buy” rating given on Friday, October 13 by Bank of America. The company was upgraded on Friday, January 22 by Deutsche Bank.

Since June 8, 2017, it had 0 buys, and 1 sale for $576,696 activity. 6,500 shares were sold by TILDEN BRADLEY D, worth $576,696. $635,947 worth of Alaska Air Group, Inc. (NYSE:ALK) was sold by SPRAGUE JOSEPH A on Thursday, June 8.

Analysts await Clovis Oncology, Inc. (NASDAQ:CLVS) to report earnings on February, 28. They expect $-1.27 EPS, up 30.60% or $0.56 from last year’s $-1.83 per share. After $-1.24 actual EPS reported by Clovis Oncology, Inc. for the previous quarter, Wall Street now forecasts 2.42% negative EPS growth.

Since June 15, 2017, it had 0 insider buys, and 1 insider sale for $185,460 activity. On Thursday, June 15 IVERS-READ GILLIAN C sold $185,460 worth of Clovis Oncology, Inc. (NASDAQ:CLVS) or 3,000 shares.

Investors sentiment decreased to 1.81 in Q2 2017. Its down 0.66, from 2.47 in 2017Q1. It worsened, as 33 investors sold CLVS shares while 56 reduced holdings. 74 funds opened positions while 87 raised stakes. 46.46 million shares or 12.58% more from 41.27 million shares in 2017Q1 were reported. Fifth Third Comml Bank stated it has 212 shares or 0% of all its holdings. 31,900 were accumulated by Sectoral Asset. Invesco Limited stated it has 411,024 shares or 0.01% of all its holdings. Venbio Select Advisor Limited Liability Company holds 140,700 shares. Mufg Americas has 501 shares for 0% of their portfolio. Opus Point Ptnrs Mngmt Limited reported 1.29% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). California State Teachers Retirement Sys reported 76,735 shares. Farallon Capital Management Ltd Liability Com has invested 0.59% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). Westfield Mgmt Co LP accumulated 0.25% or 315,170 shares. Canada Pension Plan Invest Board reported 0.01% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). Td Asset Management has invested 0.01% in Clovis Oncology, Inc. (NASDAQ:CLVS). Arrowgrass Cap Partners (Us) Limited Partnership owns 174,569 shares or 0.12% of their US portfolio. Ameritas Inv Ptnrs invested in 3,725 shares or 0.02% of the stock. State Board Of Administration Of Florida Retirement Sys reported 23,863 shares stake. Blackstone Grp LP reported 3,278 shares.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 14 have Buy rating, 0 Sell and 6 Hold. Therefore 70% are positive. Clovis Oncology had 54 analyst reports since September 10, 2015 according to SRatingsIntel. Suntrust Robinson maintained the stock with “Buy” rating in Wednesday, August 24 report. The rating was initiated by Credit Suisse with “Outperform” on Thursday, January 21. The firm earned “Buy” rating on Monday, July 31 by Leerink Swann. Morgan Stanley initiated the shares of CLVS in report on Friday, January 13 with “Overweight” rating. Credit Suisse upgraded Clovis Oncology, Inc. (NASDAQ:CLVS) rating on Wednesday, September 21. Credit Suisse has “Outperform” rating and $41 target. The firm earned “Buy” rating on Wednesday, September 6 by J.P. Morgan. On Thursday, June 1 the stock rating was maintained by J.P. Morgan with “Buy”. The firm has “Neutral” rating by Chardan Capital Markets given on Monday, June 19. Chardan Capital Markets upgraded Clovis Oncology, Inc. (NASDAQ:CLVS) rating on Tuesday, December 20. Chardan Capital Markets has “Neutral” rating and $36 target. Stifel Nicolaus maintained the shares of CLVS in report on Monday, September 11 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com